Digital Heroes Marks 2,000 Brand Launches Across 55 Countries Through Global Technology Services 
ANT Law Firm Strengthens Its Orlando Legal Services for Car Accident, Slip and Fall, and Wrongful Death Victims 
LumenIsle Launches Australian Market Service Review and International Video Traceability Initiative for Memorial Diamonds 
HiBob Named Best HR Management Software in the UK for 2026 
Ionik Announces 30-Day Extension of Senior Debt Facility Marrone Bio Advances Novel Herbicides
Three Biological-Based Herbicides Enter Late-Stage Development Phases; Potential $27 Billion Market DAVIS, Calif., Sept. 28,…
Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections
– Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported…
Fortress Biotech to Participate in the Benzinga Healthcare Small Cap Conference
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences
Christine Brown, Ph.D., of City of Hope will present at the First Annual Conference on…
Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available for Prescription for the Acute Treatment of Migraine
Trudhesa is the First and Only Therapeutic to Use POD® Technology to Deliver Dihydroergotamine Mesylate…
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Redefining Standards, Refining Psychiatry
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Tryp Therapeutics Inc. (CSE:…
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Outlook Therapeutics Reports New Positive 12-Month Safety Data from Pivotal Phase 3 NORSE TWO Trial
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with…
GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity
Study to focus on women of African American descent for expanded polygenic risk test MELBOURNE,…
Senti Bio Awarded Funding from National Cancer Institute (NCI) to Support Development of Logic Gated Allogeneic CAR-NK Cell Therapy SENTI-202 to Treat Acute Myeloid Leukemia
– Small Business Innovation Research (SBIR) contract to support development of pipeline program SENTI-202, a…
Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics
Partnership to focus on empowering women to take ownership of their health and healthcare options…
POINT Biopharma Releases New Data and Exercises Option for Best-in-Class FAP Inhibitor
Unique FAP targeting warhead combined with Actinium-225 or Lutetium-177 demonstrated complete tumor regression and long-term…
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th
Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET NEW YORK, NY,…
Iterum Therapeutics Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
DUBLIN, Ireland and CHICAGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials
— ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO…
Motus GI Announces the Passing of Independent Director Dr. Sam Nussbaum
FORT LAUDERDALE, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc. (NASDAQ: MOTS)…
Cue Biopharma Announces Publication in Nature Journal, Scientific Reports, of Immunotherapeutic Platforms Immuno-STAT and Neo-STAT
Research demonstrates that platform technologies generate therapeutic molecules for selective delivery of immune activating signals,…
Longeveron Announces Multiple Presentations at the 11th Annual International Conference on Frailty & Sarcopenia Research
MIAMI, Sept. 28, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical…
Verizon and Yealink Introduce the Nation’s First 4G/LTE Cellular Desk Phone
What you need to know: The One Talk T67LTE 4G Desk Phone is the first…